Abraham Ceesay

Insider Reports History

Location
Burlington, MA
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Abraham Ceesay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Chief Executive Officer, Director Common Stock 568K $17.6M $31.04 17 Dec 2025 Direct
Rapport Therapeutics, Inc. Chief Executive Officer, Director Common Stock 81.7K $2.34M $28.58 17 Dec 2025 By Ceesay Family Irrevocable Trust
Cerevel Therapeutics Holdings, Inc. President Restricted Stock Units 29.1K $1.23M $42.24 06 Feb 2023 Direct
Rapport Therapeutics, Inc. Chief Executive Officer, Director Common Stock 30.9K $959K $31.04 17 Dec 2025 By Dorothy Ceesay Irrevocable Trust
Pacira BioSciences, Inc. Director Stock Option (Right to Buy) 11.3K $324K $26.59 11 Jun 2025 Direct
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director Stock Options (Right to Buy) 2.08K $281K $135.04 02 Jun 2025 Direct
Pacira BioSciences, Inc. Director Common Stock 9.04K $246K $27.19 04 Sep 2025 Direct
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director Common Stock 946 $128K $135.04 02 Jun 2025 Direct
Rapport Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 428K 03 Feb 2025 Direct
Cerevel Therapeutics Holdings, Inc. President Stock Option (Right to Buy) 114K 06 Feb 2023 Direct

Insider Reports Filed by Abraham Ceesay

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RAPP Rapport Therapeutics, Inc. 17 Dec 2025 6 -$324K 4 Chief Executive Officer, Director 18 Dec 2025, 16:11
RAPP Rapport Therapeutics, Inc. 17 Nov 2025 4 -$275K 4 Chief Executive Officer, Director 18 Nov 2025, 16:27
RAPP Rapport Therapeutics, Inc. 15 Oct 2025 4 -$282K 4 Chief Executive Officer, Director 16 Oct 2025, 16:30
RAPP Rapport Therapeutics, Inc. 17 Sep 2025 4 -$2.01M 4 Chief Executive Officer, Director 19 Sep 2025, 16:05
PCRX Pacira BioSciences, Inc. 04 Sep 2025 1 -$64K 4 Director 08 Sep 2025, 17:37
PCRX Pacira BioSciences, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:18
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 02 Jun 2025 2 $409K 4 Director 04 Jun 2025, 16:45
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 20 May 2025 0 $0 3 Director 29 May 2025, 17:29
RAPP Rapport Therapeutics, Inc. 03 Feb 2025 1 $0 4 Chief Executive Officer, Director 04 Feb 2025, 17:30
PCRX Pacira BioSciences, Inc. 12 Jun 2024 2 $0 4 Director 13 Jun 2024, 18:13
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 1 $0 4 Chief Executive Officer, Director 10 Jun 2024, 19:39
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 0 $0 3 Chief Executive Officer, Director 06 Jun 2024, 18:49
PCRX Pacira BioSciences, Inc. 06 Oct 2023 1 $0 4 Director 11 Oct 2023, 16:46
PCRX Pacira BioSciences, Inc. 06 Oct 2023 0 $0 3 Director 11 Oct 2023, 16:42
CERE Cerevel Therapeutics Holdings, Inc. 06 Feb 2023 2 $0 4 President 08 Feb 2023, 19:29
CERE Cerevel Therapeutics Holdings, Inc. 08 Sep 2022 3 -$371K 4 President 12 Sep 2022, 16:24
CERE Cerevel Therapeutics Holdings, Inc. 22 Aug 2022 3 -$186K 4 President 24 Aug 2022, 16:05
CERE Cerevel Therapeutics Holdings, Inc. 15 Aug 2022 3 -$201K 4 President 17 Aug 2022, 16:15
CERE Cerevel Therapeutics Holdings, Inc. 05 Aug 2022 7 -$1.23M 4 President 09 Aug 2022, 20:59
CERE Cerevel Therapeutics Holdings, Inc. 09 Feb 2022 1 $0 4 President 11 Feb 2022, 17:46
CERE Cerevel Therapeutics Holdings, Inc. 01 Jun 2021 1 $0 4 President 03 Jun 2021, 16:24
CERE Cerevel Therapeutics Holdings, Inc. 03 May 2021 0 $0 3 President 13 May 2021, 18:47